MedSafety Solutions Earns EU-MDR Certification

Meets New, Strengthened Requirements for Safety and Performance

MedSafety Solutions today announced that it has received the European Union Medical Devices Regulations (EU-MDR) certification as of September 9, 2021.

This achievement is a major milestone for MedSafety Solutions in its ongoing mission to provide hospital pharmacies in the European market with the products and expertise they need to perform safely and effectively.

The British Standards Institution BSI completed their conformity assessment to include quality management systems as well as general safety and performance standards. As a result of this assessment, conducted by audit and technical review, BSI determined that MedSafety Solutions met the needed requirements and issued its EU Quality Management System Certificate.

“Receiving this certification demonstrates our commitment to compliance with new regulations and to meeting customers’ needs safely and predictably,” says Steve van Engen, founder and CEO at MedSafety Solutions. “Additionally, receiving this certification ahead of many other companies will serve as a distinct competitive advantage.”

This news takes on significant importance in that the new certification:

  • Is significantly more stringent than the Medical Devices Directive (MDD), the previous regulatory framework
  • Comes as a result of strict performance assessments of MedSafety Solution’s quality management systems and an evaluation of general safety and performance indicators
  • Enables MedSafety Solutions to advance its position in the European market

To learn more about the EU-MDR certification, click here to contact us.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version